PharmaTimes -
October 2015
News
News ReviewCDF shake-up / GPs and pharma’s growing divide / Dead end for off-patent drugs bill / Pharma’s transparency drive
SmartViews
Education, education, educationPharma has a crucial role in providing medical education, but must be fully transparent
Rise of the machines
Artificial intelligence is the key to smarter procurement and cost savings
Medical devices under the microscope
Medical devices could soon come under increased scrutiny as the EU’s new regulation proposals enter final discussions
Power trip
Pharma companies in a dominant market position need to be sure they are not abusing their position or risk the consequences
Battle of the Pacific
What the Trans-Pacific trade deal means for pharma
SmartDeals
Recent trends in pharma M&A / Pfizer in talks to acquire Allergan / AstraZeneca snaps up ZS Pharma / Shire buys potential competitor Dyax
Features
Taking a breathPharma’s role in tackling the challenges of Chronic Obstructive Pulmonary Disease
Voyage of rediscovery
Repurposing drugs can be a quick, inexpensive solution to diseases, but pharma has to be careful when repricing older medicines
People
SmartPeopleUniphar’s Padraic Dempsey on the healthcare industry in the UK and Ireland
Movers
This month’s job moves and new appointments
49 PatientFiles
COPD patient Joan McCarthy says that pharma could do more to educate COPD patients
Business Insight
ZenopaIt only takes one applicant to fill a job